ʻSensitizingʼ Test Paradigms: Study Design.
收藏数据链接：
官方服务：
资源简介：
△ Objectives related to the specific perspectives of the review.† ratio of placebo-treated vs. naloxone-treated was 0.5.# study design is for remifentanil-placebo infusions.For explanation of abbreviations, please refer to legend Table 1.ʻSensitizingʼ Test Paradigms: Study Design.
创建时间：
2015-12-03
相关数据集
暂无相关数据集
